A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy

Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus

NCT07258394 ·Status: RECRUITING ·Phase: PHASE3

Modulation of Human Myocardial Metabolism by GLP-1 Dose Response

NCT01607450 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Phase 1 Study in Diabetes Mellitus(Fasting)

NCT06552182 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating the Safety and Feasibility of Endoscopic Duodenal Injections of Autologous Mesenchymal Stem Cells

NCT07344324 ·Status: NOT_YET_RECRUITING ·Phase: NA

Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes

NCT01509742 ·Status: COMPLETED ·Phase: PHASE1

Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

NCT00004700 ·Status: COMPLETED ·Phase: PHASE2

Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes

NCT06671340 ·Status: NOT_YET_RECRUITING ·Phase: NA

Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial

NCT00975533 ·Status: UNKNOWN ·Phase: PHASE3

A Study of Dulaglutide in Chinese Participants

NCT01667900 ·Status: COMPLETED ·Phase: PHASE1

First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.

NCT03444467 ·Status: COMPLETED ·Phase: PHASE1

Effect of Islet Autotransplantation Compared to Oral Antidiabetic Drug.

NCT01922492 ·Status: UNKNOWN ·Phase: NA

GLP-1 RA for Stage 1 Type 1 Diabetes

NCT07430332 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy

NCT04216849 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment

NCT00530686 ·Status: COMPLETED ·Phase: PHASE1

The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans

NCT02403284 ·Status: COMPLETED ·Phase: PHASE4

Leptin to Treat Severe Insulin Resistance - Pilot Study

NCT00027456 ·Status: COMPLETED ·Phase: PHASE2

Incretin Regulation of Insulin Secretion in Monogenic Diabetes

NCT01795144 ·Status: COMPLETED ·Phase: PHASE1

Human Models of Selective Insulin Resistance: Pancreatic Clamp

NCT06558422 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes

NCT06976619 ·Status: RECRUITING ·Phase: PHASE2

A Study That Will Evaluate Ketogenesis and Glucose-Dependent Insulin Secretion Methodologies in Healthy Male Subjects (MK-0000-159)(COMPLETED)

NCT01055340 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function

NCT02443155 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

NCT04027023 ·Status: UNKNOWN ·Phase: PHASE4

The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)

NCT01449019 ·Status: COMPLETED ·Phase: PHASE1

Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes

NCT05294822 ·Status: UNKNOWN ·Phase: NA

Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment

NCT04177303 ·Status: UNKNOWN ·Phase: PHASE3